• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareHealthcare Equipment & SuppliesVitrafy Life Sciences
    Picture of Vitrafy Life Sciences logo

    VFY — Vitrafy Life Sciences Share News

    AU$3.160.000.00%
    au flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    • Market Cap
      AU$201.76m
    • Enterprise Value
      AU$189.39m
    • Revenue
      AU$0.07m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • VFY Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    VFY Dividends
    • Australia's Vitrafy Life Sciences slumps on discounted placement

      12/06/2026 06:30
    • Brief: Vitrafy Life Sciences Receives Firm Commitments For A$30 Million Placement

      12/06/2026 24:52
    • Brief: Vitrafy Life Sciences Seeks Trading Halt

      09/06/2026 23:34
    • Brief: Vitrafy Life Sciences Enters Partnership With Vitalant Innovation Center

      02/06/2026 02:46
    • Brief: Vitrafy Life Sciences Posts HY Loss After Tax A$7.1 Million

      04/02/2026 01:37
    • Brief: Vitrafy Life Sciences Enters Strategic Commercial Agreement With IMV Technologies

      15/01/2026 03:54
    • Australia's Vitrafy Life Sciences rises on partnership with IMV Technologies

      15/01/2026 24:31
    • Brief: Vitrafy Life Sciences Says Chair Sonia Petering To Retire At 2025 AGM

      16/10/2025 02:22
    • Australia's Vitrafy Life Sciences flat; Bell Potter raises PT on cash flows hopes

      06/08/2025 04:26
    • Brief: Vitrafy Life Sciences Announces Leadership Transition

      05/08/2025 02:20
    • Australia's Vitrafy Life Sciences hits record low on interim loss

      06/02/2025 03:08
    • Brief: Vitrafy Life Sciences Posts HY Loss Attributable A$25.7 Million

      06/02/2025 01:11

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.